Protalix Reports Q2 2026 Earnings with Revenue Growth Driven by Elfabrio Sales
In the second quarter of 2026, Protalix (PLX) reported total revenue of $19.9 million, up from $15.7 million in the same period a year ago, primarily due to increased sales of its product Elfabrio through partnerships like Chiesi. The company raised full-year revenue guidance to between $78.0 million and $83.0 million for 2026, including a previously announced $25 million milestone payment from Chiesi. Protalix also provided updated sales forecasts: Elfabrio is expected to generate $33–$35 million in revenue this year (excluding milestones), while Elelyso is projected at $20–$23 million. The company reported a net income of $3.8 million for the quarter, or $0.05 per share, compared to just $164,000 in Q2 2025. Protalix’s cash position stood at $40.7 million as of June 30.
Tickers: $PFE
Topics: financials guidance revenue sales_performance